Bloodstram Infections in ICU. Single Centre Observational Study.

Completed

• Conditions: Bloodstream Infection; Antibiotic Resistant Strain; Intensive Care Unit

• Registration Number: NCT04926935
• Lead Sponsor: Military Institute od Medicine National Research Institute

Brief Summary

Hospital-acquired bloodstream infection (BSI) is serious care problem worldwide associated with significant morbidity and mortality. However, only few nationwide studies have focused on the incidence of BSI, and its results were often inconsistent.

The objective of this study was to analyze bloodstream infections in patients hospitalized in the intensive care unit of the tertiary, university hospital. Special attention was put on the etiology of the infections, the antimicrobial susceptibility/resistance of the isolated pathogens, as well as the incidence of central vein catheters infections in the analyzed population.

Data were collected in the intensive care unit of the Military Institute of Medicine, Warsaw, Poland, between January, 1, 2007 and December, 31, 2019.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-01
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Status Verified: 2021-06
• Study First Submitted: 2021-06-04
• Study First Submitted QC: 2021-06-08
• Last Update Submitted: 2021-06-08
• Study First Posted: 2021-06-15
• Last Update Posted: 2021-06-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3502

Inclusion Criteria

• all patients hospitalized in the ICU with clinically suspected infection.

Exclusion Criteria

• none.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Results of microbiological analysis.	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.
Isolated pathogens' susceptibility for antimicrobial agents. .	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.
Isolated pathogens' resistance for antimicrobial agents. .	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.

Trial Locations

Locations (1)

Department of Anesthesiology and Intensive Therapy; 🇵🇱 Warsaw, Poland